Haffkine Bio Pharmaceutical Corporation Limited

Haffkine Bio Pharmaceutical Corporation Limited has published Supply Of Injections Phase I (2020-21) , name of the item : , adrenaline 1 mg / ml inj , amikacin sulphate 500 mg inj , amikacine sulphate250 mg - 2 ml inj . , amikacin sulphate 100 mg inj , aminophylline inj 25mg / ml , amoxycillin + calvulanic acid 1 . 2 gm ( amoxycillin sodium 1000 mg + clavulanic acid as potassium salt 200 mg i . e . 1 . 2 gm in vial inj ) , amoxycillin + calvulanic acid 300 mg inj . ( amoxycillin sodium 250mg + clavulanic acid 50 mg per vial inj ) , amoxycillin sodium 500mg + clavulanic acid 100mg per vial inj , ampicillin 500 mg inj , anti-d immunoglobulin inj mono / polyclonal 300 mcg , artesunate 60 mg vial inj . , atracurium besylate 10mg / ml inj , atropine sulphate 0 . 6 mg / ml inj , betamethasone 4mg / ml inj , benzathine penicillin g 12 , 00 , 000 i . u . / vial inj , bupivacaine hydrochloride ( heavy ) 5 mg + dextrose monohydrate 80 mg / ml inj , bupivacaine heavy mixed with glucose solution inj . 4 ml , calcium gluconate 10 % w / v inj , cefoperazone and sulbactum 2gm inj , cefoperazone and sulbactum 1 gm inj , cefotaxime 1000 mg inj , cefatoxime 500 mg inj . , ceftazidime 1000 mg inj , ceftazidime inj 500 mg , ceftriaxone 1000 mg inj , ceftrixone 500 mg inj . , cefuroxime 750 mg inj , daltiparin 2500 iu ( low molecular weight heparin 2500 iu ) , dalteparine sodium5000 iu anti factor inj , desflurane , dexamethasone sodium phosphate 4 mg / ml inj . , diazepam 5 mg / ml inj , diclofenac 25 mg / ml inj , diclofenac sodium 75 mg / ml inj iv bolus injection 1 ml amp , dicyclomine hydrochloride inj . 10mg / ml , dobutamine inj . 50mg / ml , dopamine hci . 40 mg / ml ( i . e . 200 mg / 5 ml ) inj , dulaglutide 1 . 5mg / vial inj . , enoxaparin sodium 40mg inj , enoxaparin sodium 60mg inj , erythropoitin 4000 i . u . inj , erythropoetin recombinant inj 2000 iu , erythropoitin 10000 i . u . inj , ethamsylate inj . 125mg / ml , 2ml amp , etophylline 169 . 4 mg + theophyllin 50 . 6 mg inj , frusemide 10mg / ml inj , gentamycin sulphate 40mg inj , haloperidol deconoate depot inj . 50 mg / ml , heparin sodium 1000 i . u . / ml inj , heparin sodium 5000 i . u . / ml inj , hepatitis b immunoglobulin 100 i . u . , hepatitis b immunoglobulin 200 i . u . , human insulin plain 40iu / ml , human- albumin 20% inj , insulin lispro mix 25 / 75 pen with needle pack size - 1 pen with needle , hyluronidase inj . 2ml , hydroxy propyl methyl cellulose usp 2% in sterile isonic base pfs inj , human normal immunoglobulin for intravenous use 5gm , human tetanus immunoglobulin 250 i . u . inj , antitetanus human immunoglobin inj , antitetanus human immunoglobin inj , hydrocortisone sodium succinate 100 mg / vial inj , hydroxyethyl starch ( hetastarch ) inj 6% 500ml , imipenem 500 mg + cillastatin 500 mg per vial inj , infliximab 100 mg inj . , iron sucrose 20mg / ml inj , isoflurane ( usp / ip / bp ) , ketamine hydrochloride 50mg / ml inj , lignocaine or lidocaine or xylocaine hcl 0 . 01 ( 1% ) 30 ml inj , lignocaine or lidocaine or xylocaine hcl 0 . 02 ( 1% ) 30 ml inj , lignocaine hydrochloride ip with dextrose hyperbaric ( heavy ) inj , lignocaine or lidocaine or xylocaine hcl 20mg , adrenaline or epinephrine 5mcg , per ml ) 30ml inj , inj . lorazepam 2mg , inj magnesium sulphate 50% w / v , mephentermine sulphate 35mg / ml-10 ml inj , meropenam 1 gm inj , meropenam 500 mg inj , methyl ergometrine maleate 0 . 2 mg / ml inj , methyl prednisolone acetate 40mg / ml - 1 ml or 2 ml inj , methyl prednisolone inj 125mg / 2ml , methyl prednisolone sodium succinate 500 mg / vial inj , methyl prednisolone sodium succinate 1 gm / vial inj , metoclopramide hydrochloride 5 mg / ml inj , midazolam 1mg / ml inj , neostigmine methyl sulphate 0 . 5 mg / ml inj , nitroglycerine 5 mg / ml inj , noradrenaline 2 mg / ml inj , ondansetron inj ip 2 mg / ml inj , oxytocin 5 i . u . / ml inj , inj . paliperidone palmitate 75mg , inj . paliperidone palmitate 100mg , pantaprazole 40 mg / 10 ml inj , paracetamol 150 mg / ml inj , paracetamol 10 mg / ml inj , pentazocine lactate 30 mg / ml inj , phenytoin sodium 50 mg / ml - 2 ml ( diphenyl hadantoin sodium ) inj . , piperacilin 4gm + tazobactum 0 . 5 g inj , pralidoxime chloride 500 mg ( pam ) inj . , pralidoxime chloride 1 gm ( pam ) inj . , promethazine inj 50mg / ml , propofol 1% mct / lct in fat emulsion with oleic acid i . e . 10 mg / ml - 20 ml vial inj , inj propofol 2% mct / lct in fat emulsion with oleic acid i . e . 10 mg / ml - 10 ml vial / amp , prostaglandin ( carboprost ) inj . 250mcg / ml , rabies immunoglobin - anti rabies serum , rabies immunoglobulin 300 iu / ml inj , rabies vaccines , human ( cell culture ) potency of not less than 2 . 5 units per vial . i . p . for id use ( tissue culture anti rabies vaccines ) inj , rabies vaccines , human ( cell culture ) potency of not less than 2 . 5 units per vial . i . p . for im use ( tissue culture anti rabies vaccines ) inj , risperidone 25mg inj . , rocuronium 50 mg / 5 ml inj , sevoflourane , sevoflourane 100 ml , sodium bicarbonate inj . , sodium nitropruside 50 mg inj , sterile water for injection , sterile water for injection , streptokinase 7 . 5 lac i . u . inj , streptokinase 15 lac i . u . inj , inj . tenecteplase 20 mg , inj . tenecteplase 40mg , tetanus toxoid ( adsorbed ) , tramadol 50 mg / ml inj , tranxamic acid 500 mg / 5 ml , urokinase inj . 10 lac iu , vancomycin 500 mg inj , vancomycin 1 gm inj . , vecuronium bromide 4 mg inj , vitamin k3 water soluble inj , premix insulin 30:70 injection recombinant human insulinbiphasic 30% , regular 70% 100 iu / ml , inj . lung surfactant 5ml , surfactant for intratrecheal instillation ( natural bovine lung surfactant ) minimum labelled shelf life ( in months 18 ) , surfactant for intratrecheal instillation ( natural bovine lung surfactant ) minimum labelled shelf life ( in months 18 ) , non ionic 370 iopromide / ioversol / iohexol / iopamidol 370 mg / ml / iobitridol 350 mg indian fda / dcgi approved with who gmp certificate or us fda or ce approved , non ionic 370 iopromide / ioversol / iohexol / iopamidol 370 mg / ml / iobitridol 350 mg india fda / dcgi approved with who gmp certificate or us fda or ce approved , non- ionic 300 iopromide / ioversol / iohexol / iopamidol 300 mg / mlindia fda / dcgi approved with who gmp certificate or us fda or ce approved , mri contrast media inj . gadolinium / gadoversetamide / gadodiamide / gadopentetate 0 . 5 molar 0 . 5 mmol / ml / gadoteric acid indian fda / dcgi approved with who gmp certificate or us fda or ce approved. Last date of submission for this tender is 2021-04-29. This is a Medicine tender in Md, Hbpcl,acharya Donde Marg, Parel, Mumbai, Maharashtra